Discussion
While stenting is widely used in cardiology, only limited experience has been gathered on its use in carotid artery disease [1, 2] . About 5,210 procedures have been reported worldwide (technical success rate 98.4%; transient ischemic attacks 2.82%, minor strokes 2.72%, major strokes, 1.49%; deaths 0.86%) [1] . Various clinical trials are being planned or are in progress to establish the indications for carotid artery stenting (CREST, SPACE, CASET) [6] . Recently, the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS) demonstrated similar 3-year results for endovascular treatment and carotid endarterectomy for major risks and effectiveness, and avoidance of minor complications [7] . Stent thrombosis is a well-known problem in cardiology [8] . A thrombosis rate of 3.5% was reported as a first result [8] . Aggressive antiplatelet therapy, including the combined use of ticlopidin or clopidogrel and aspirin, reduces the rate of stent thrombosis to approximately 1% [8] . Platelet activation and aggregation may play a relevant role in the treatment of thrombotic occlusion of stented vessel segments [9] . Abciximab has been proposed in carotid stenting to prevent rethrombosis [9] . The treatment of early intracoronary stent thrombosis includes balloon angioplasty and intracoronary thrombolysis. Systemic thrombolysis has so far been attempted as a second therapeutic alternative [10] . We performed an intravenous rt-PA thrombolysis similar to the known NINDS protocol to reperfuse the MCA. In contrast to this protocol, heparin was given early because we hoped it would prevent another thrombosis, and indeed both the MCA and the thrombosed stent were recanalized. Thus, thrombolysis was able to dissolve a large thrombus in the stent and an embolus in the MCA. After the intervention, we discovered a recent case report about the intravenous administration of a glycoprotein IIb/IIIa receptor antagonist to recanalize acute stent thrombosis [7] . To the best of our knowledge, this is the first report of the use of intravenous thrombolysis to successfully recanalize a carotid stent thrombosis with concomitant embolic MCA occlusion. Obviously, this single case can only help to illuminate the available treatment options rather than provide general therapeutic recommendations. 
